|
Monitoring and treatment of MDS in genetically susceptible persons |
Dec 2019 |
Hematology. American Society of Hematology. Education Program |
Myelodysplastic Syndromes (MDS) |
|
Idiopathic aplastic anemia vs hypocellular myelodysplastic syndrome |
Dec 2019 |
Hematology. American Society of Hematology. Education Program |
Aplastic Anemia |
|
Genetic predisposition to MDS: diagnosis and management |
Dec 2019 |
Hematology. American Society of Hematology. Education Program |
Myelodysplastic Syndromes (MDS) |
|
Lowering the boom on lower-risk myelodysplastic syndromes |
Dec 2019 |
Hematology. American Society of Hematology. Education Program |
Myelodysplastic Syndromes (MDS) |
|
Distinct and convergent consequences of splice factor mutations in myelodysplastic syndromes |
Nov 2019 |
American Journal of Hematology |
Myelodysplastic Syndromes (MDS) |
|
The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion |
Oct 2019 |
Annals of Hematology |
Myelodysplastic Syndromes (MDS) |
|
Paroxysmal nocturnal hemoglobinuria without GPI-anchor deficiency |
Oct 2019 |
The Journal of Clinical Investigation |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
|
Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia |
Oct 2019 |
Blood Advances |
Aplastic Anemia |
|
Similar outcomes of alemtuzumab-based hematopoietic cell transplantation for SAA patients older or younger than 50 years |
Oct 2019 |
Blood Advances |
Aplastic Anemia |
|
DNA methylation identifies genetically and prognostically distinct subtypes of myelodysplastic syndromes |
Oct 2019 |
Blood Advances |
Myelodysplastic Syndromes (MDS) |
